Topical gabapentin solution for the management of burning mouth syndrome: A retrospective study
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0295559 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Amanda Gramacy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, California, United States of America. Hauptthemen laut MEDLINE: Burning Mouth Syndrome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The aim of this retrospective study was to evaluate the effectiveness and safety of topical gabapentin solution (250 mg/mL) for the management of burning mouth syndrome (BMS). Study design A retrospective chart review was conducted of all patients diagnosed with BMS and managed with gabapentin 250 mg/mL solution (swish and spit) between January 2021 and October 2022. Patient-reported outcomes included changes in burning score ranked on a 10-point numeric rating scale (NRS) and reported adverse drug reactions (ADR). Wilcoxon signed-rank test was used to assess differences in the oral burning score ranked on a NRS (0–10) between the baseline visit and the second visit.
Results
A total of 19 patients (68.4% females) with BMS were included and evaluated for follow-up at a median of 86 days (range: 29–195). Overall, patients reported a median 2-point burning decrease on a 0–10 NRS between the baseline visit and the second visit (p < 0.01). ADRs were reported by 3 patients (15.8%).
Conclusion
Although this was a small retrospective study, BMS management with topical gabapentin (250 mg/mL) appears to be effective and well-tolerated. Future randomized prospective studies are needed to verify these preliminary findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, California, United States of America.
- Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, United States of America.
ORCID-Profile: Amanda Gramacy, Alessandro Villa
Zitieren
APA
Gramacy, A., & Villa, A. (2023). Topical gabapentin solution for the management of burning mouth syndrome: A retrospective study. PLOS ONE. https://doi.org/10.1371/journal.pone.0295559
Vancouver
Gramacy A, Villa A. Topical gabapentin solution for the management of burning mouth syndrome: A retrospective study. PLOS ONE. 2023. doi:10.1371/journal.pone.0295559
BibTeX
@article{Gramacy2023,
author = {Gramacy, Amanda and Villa, Alessandro},
title = {Topical gabapentin solution for the management of burning mouth syndrome: A retrospective study},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0295559}
}
EUVIMED